| Canonical insertion-deletion markers for rapid DNA typing of Francisella tularensis P Larsson, K Svensson, L Karlsson, D Guala, M Granberg, M Forsman, ... Emerging infectious diseases 13 (11), 1725, 2007 | 82* | 2007 |
| Comparative interactomics with Funcoup 2.0 A Alexeyenko, T Schmitt, A Tjärnberg, D Guala, O Frings, ... Nucleic acids research 40 (D1), D821-D828, 2012 | 66 | 2012 |
| FunCoup 4: new species, data, and visualization C Ogris, D Guala, M Kaduk, ELL Sonnhammer Nucleic acids research 46 (D1), D601-D607, 2018 | 58 | 2018 |
| A large-scale benchmark of gene prioritization methods D Guala, ELL Sonnhammer Scientific reports 7 (1), 46598, 2017 | 55 | 2017 |
| A novel method for crosstalk analysis of biological networks: improving accuracy of pathway annotation C Ogris, D Guala, T Helleday, ELL Sonnhammer Nucleic acids research 45 (2), e8-e8, 2017 | 46 | 2017 |
| MaxLink: network-based prioritization of genes tightly linked to a disease seed set D Guala, E Sjölund, ELL Sonnhammer Bioinformatics 30 (18), 2689-2690, 2014 | 36 | 2014 |
| FunCoup 5: functional association networks in all domains of life, supporting directed links and tissue-specificity E Persson, M Castresana-Aguirre, D Buzzao, D Guala, ELL Sonnhammer Journal of molecular biology 433 (11), 166835, 2021 | 32 | 2021 |
| Genome-wide functional association networks: background, data & state-of-the-art resources D Guala, C Ogris, N Müller, ELL Sonnhammer Briefings in bioinformatics 21 (4), 1224-1237, 2020 | 29 | 2020 |
| RebiQoL: A randomized trial of telemedicine patient support program for health-related quality of life and adherence in people with MS treated with Rebif AM Landtblom, D Guala, C Martin, S Olsson-Hau, S Haghighi, L Jansson, ... PLoS One 14 (7), e0218453, 2019 | 14 | 2019 |
| Drug repurposing improves disease targeting 11-fold and can be augmented by network module targeting, applied to COVID-19 I Rivero-García, M Castresana-Aguirre, L Guglielmo, D Guala, ... Scientific reports 11 (1), 20687, 2021 | 7 | 2021 |
| TOPAS, a network-based approach to detect disease modules in a top-down fashion D Buzzao, M Castresana-Aguirre, D Guala, ELL Sonnhammer NAR Genomics and Bioinformatics 4 (4), lqac093, 2022 | 5 | 2022 |
| Experimental validation of predicted cancer genes using FRET D Guala, K Bernhem, HA Blal, D Jans, E Lundberg, H Brismar, ... Methods and applications in fluorescence 6 (3), 035007, 2018 | 3 | 2018 |
| Benchmarking enrichment analysis methods with the disease pathway network D Buzzao, M Castresana-Aguirre, D Guala, ELL Sonnhammer Briefings in Bioinformatics 25 (2), bbae069, 2024 | 2 | 2024 |
| Benefits and challenges of Pre-clustered network-based pathway analysis M Castresana-Aguirre, D Guala, ELL Sonnhammer Frontiers in Genetics 13, 855766, 2022 | 2 | 2022 |
| Network crosstalk as a basis for drug repurposing D Guala, ELL Sonnhammer Frontiers in genetics 13, 792090, 2022 | 2 | 2022 |
| MODalyseR—a novel software for inference of disease module hub regulators identified a putative multiple sclerosis regulator supported by independent eQTL data HA de Weerd, J Åkesson, D Guala, M Gustafsson, Z Lubovac-Pilav Bioinformatics Advances 2 (1), vbac006, 2022 | 1 | 2022 |
| Drug repurposing improves disease targeting 11-fold on average. New insights from network module targeting and its application to COVID-19. I Rivero, M Castresana, D Guala, E Sonnhammer OSF Preprints, 2020 | 1 | 2020 |
| Functional association networks for disease gene prediction D Guala Department of Biochemistry and Biophysics, Stockholm University, 2017 | 1 | 2017 |
| Francisella tularensis P Larsson, K Svensson, L Karlsson, D Guala, M Granberg, M Forsman, ... | 1 | 2007 |
| Cultured lymphocytes’ mitochondrial genome integrity is not altered by cladribine E Järvinen, F Suomi, JB Stewart, D Guala, M Valori, L Jansson, ... Clinical and Experimental Immunology 214 (3), 304-313, 2023 | | 2023 |
